Eva Rosenberg

Title: Eva Rosenberg: Innovator in Polypeptide Purification

Introduction

Eva Rosenberg is a distinguished inventor based in Munich, Germany. She has made significant contributions to the field of biochemistry, particularly in the purification of recombinantly produced polypeptides. With a total of 4 patents to her name, her work has had a profound impact on the industry.

Latest Patents

One of her latest patents focuses on immunoglobulin aggregate removal. This innovative method utilizes chromatographic techniques to eliminate high molecular weight compounds from polypeptides. Underivatized controlled pore glass (uCPG) has been identified as a selective binding agent for these compounds. The purification process is most effective at a pH range of 4 to 6 in buffered solutions. With the application of approximately 100 to 150 m² of uCPG surface per gram of polypeptide, her method can remove 80% to 95% of high molecular weight compounds while achieving a yield of 80% to 90% of the desired polypeptide.

Career Highlights

Eva has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Throughout her career, Eva has collaborated with notable colleagues such as Stefan Hepbildikler and Wolfgang Kuhne. These partnerships have further enhanced her innovative capabilities and expanded her professional network.

Conclusion

Eva Rosenberg is a remarkable inventor whose work in polypeptide purification continues to influence the biochemistry landscape. Her patents and collaborations reflect her dedication to advancing scientific knowledge and improving industry practices.